Farther Finance Advisors’s Medifast MED Stock Holding History

Farther Finance Advisors’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$434	Buy	+43	New	+$464	﹤0.01%	5301
2025 Q4	–	Sell	-64	Closed	-$875	–	5539
2025 Q3	$875	Buy	+64	New	+$894	﹤0.01%	4406
2025 Q1	–	Sell	-4	Closed	-$70	–	4374
2024 Q4	$70	Hold	4	–	–	﹤0.01%	3838
2024 Q3	$77	Sell	4 -40	-91%	-$771	﹤0.01%	3819
2024 Q2	$925	Buy	44 +36	+450%	+$960	﹤0.01%	3104
2024 Q1	$300	Sell	8 -6	-43%	-$291	﹤0.01%	3168
2023 Q4	$941	Sell	14 -9	-39%	-$627	﹤0.01%	2764
2023 Q3	$1.72K	Buy	23 +4	+21%	+$355	﹤0.01%	1912
2023 Q2	$1.75K	Hold	19	–	–	﹤0.01%	1800
2023 Q1	$1.97K	Hold	19	–	–	﹤0.01%	1654
2022 Q4	$2.19K	Buy	+19	New	+$2.21K	﹤0.01%	1420

Other funds holding MED

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group London, United Kingdom $48.2B AUM 24.23% 1-Year Est. Return